Natural Product: NPC252292

Natural Product IDNPC252292
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Jionoside D
IUPAC Name [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Synonyms Jionoside D
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL555710
PubChem CID 9895632
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WKQLGHCWJNLUKK-CPPDSBOHSA-N
Standard InCHI InChI=1S/C30H38O15/c1-14-23(36)24(37)25(38)30(42-14)45-28-26(39)29(41-10-9-16-4-7-20(40-2)19(34)12-16)43-21(13-31)27(28)44-22(35)8-5-15-3-6-17(32)18(33)11-15/h3-8,11-12,14,21,23-34,36-39H,9-10,13H2,1-2H3/b8-5+/t14-,21+,23-,24+,25+,26+,27+,28+,29+,30-/m0/s1
SMILES C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]1[C@H]([C@H](OCCc2ccc(c(c2)O)OC)O[C@H](CO)[C@H]1OC(=O)/C=C/c1ccc(c(c1)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   638.22 Volume:   603.972
?
Van der Waals volume.
Dense:   1.057 LogP:   -0.121
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.748
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.38
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   12.0 Rigid Bonds:   26.0
TPSA:   234.29
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   8.0 Rings:   4.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.086 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.707 Fsp3:   0.5
MCE-18:   99.889
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.729 Fluc inhibitor:   0.665
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.154
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.554
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.143 Promiscuous compounds:   0.326

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.325 MDCK Permeability:   -5.37
Pgp-inhibitor:   0.001 Pgp-substrate:   0.575
PAMPA:   0.999
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.757
20% Bioavailability (F20%):   0.978 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.022
Plasma Protein Binding (PPB):   73.024% Volume Distribution (VD):   -0.269
Fu: 24.398%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.005
BSEP inhibitor:   0.005

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.002
CYP2C9-inhibitor:   0.072 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.109 CYP3A4-substrate:   0.985
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.77
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.629 Half-life (T1/2):  3.545

ADMET: Toxicity

hERG Blockers:  0.052 hERG Blockers (10um):  0.339
Human Hepatotoxicity (H-HT):  0.362 Drug-induced Liver Injury (DILI):  0.664
AMES Toxicity:  0.954 Rat Oral Acute Toxicity:  0.01
Maximum Recommended Daily Dose:  0.026 Skin Sensitization:  1.0
Carcinogencity:  0.032 Eye Corrosion:  0.0
Eye Irritation:  0.037 Respiratory Toxicity:  0.005
Drug-induced Neurotoxicity:  0.001 Ototoxicity:  0.993
Hematotoxicity:  0.139 Drug-induced Nephrotoxicity:  0.471
Genotoxicity:  0.158 RPMI-8226 Immunitoxicity:  0.088
A549 Cytotoxicity:  0.949 Hek293 Cytotoxicity:  0.638
BCF:   0.576
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.284
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.946
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.225
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28152 Jacaranda caucana Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[19361168]
NPO33389 strobilanthes cusia Species Acanthaceae Eukaryota aerial parts n.a. n.a. PMID[25427242]
NPO28152 Jacaranda caucana Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28152 Jacaranda caucana Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. EC50 = 1100.0 nM PMID[19361168]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC252292 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.881 High Similarity NPC34927
0.8625 High Similarity NPC472350
0.8625 High Similarity NPC197316
0.8625 High Similarity NPC89105
0.8372 Intermediate Similarity NPC100998
0.8023 Intermediate Similarity NPC269141
0.7816 Intermediate Similarity NPC34587
0.764 Intermediate Similarity NPC112
0.75 Intermediate Similarity NPC46137
0.7396 Intermediate Similarity NPC306890
0.7391 Intermediate Similarity NPC259347
0.7368 Intermediate Similarity NPC470933
0.7159 Intermediate Similarity NPC76406
0.7143 Intermediate Similarity NPC298257
0.7143 Intermediate Similarity NPC175214
0.7126 Intermediate Similarity NPC483705
0.7079 Intermediate Similarity NPC611289
0.7045 Intermediate Similarity NPC134405
0.7011 Intermediate Similarity NPC483706
0.7 Intermediate Similarity NPC263829
0.697 Remote Similarity NPC473427
0.6774 Remote Similarity NPC205864
0.6774 Remote Similarity NPC247032
0.6737 Remote Similarity NPC96795
0.6737 Remote Similarity NPC264632
0.6667 Remote Similarity NPC300894
0.6667 Remote Similarity NPC23845
0.6634 Remote Similarity NPC94871
0.6531 Remote Similarity NPC106818
0.6526 Remote Similarity NPC296954
0.6436 Remote Similarity NPC87403
0.6304 Remote Similarity NPC68092
0.6279 Remote Similarity NPC473285
0.6186 Remote Similarity NPC600370
0.6176 Remote Similarity NPC471062
0.6163 Remote Similarity NPC35731
0.6117 Remote Similarity NPC470934
0.61 Remote Similarity NPC476382
0.6061 Remote Similarity NPC610636
0.6055 Remote Similarity NPC470927
0.6044 Remote Similarity NPC81515
0.604 Remote Similarity NPC476384
0.5981 Remote Similarity NPC476386
0.5938 Remote Similarity NPC106677
0.593 Remote Similarity NPC886
0.5914 Remote Similarity NPC64141
0.581 Remote Similarity NPC64195
0.5769 Remote Similarity NPC476381
0.5766 Remote Similarity NPC257970
0.57 Remote Similarity NPC119537
0.5619 Remote Similarity NPC476380
0.5556 Remote Similarity NPC476385
0.5524 Remote Similarity NPC196063
0.5524 Remote Similarity NPC604195
0.5464 Remote Similarity NPC222433
0.5437 Remote Similarity NPC232992
0.5417 Remote Similarity NPC205195
0.5364 Remote Similarity NPC229505
0.5354 Remote Similarity NPC476377
0.5283 Remote Similarity NPC476375
0.5222 Remote Similarity NPC287597
0.5189 Remote Similarity NPC141455
0.5179 Remote Similarity NPC188393
0.5052 Remote Similarity NPC260425
0.5052 Remote Similarity NPC235294

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC252292 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8625 High Similarity NPD7266 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data